PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NARI vs. LNTH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NARI and LNTH is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

NARI vs. LNTH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inari Medical, Inc. (NARI) and Lantheus Holdings, Inc. (LNTH). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%AugustSeptemberOctoberNovemberDecember2025
45.34%
-20.82%
NARI
LNTH

Key characteristics

Sharpe Ratio

NARI:

0.59

LNTH:

1.08

Sortino Ratio

NARI:

1.44

LNTH:

2.11

Omega Ratio

NARI:

1.19

LNTH:

1.29

Calmar Ratio

NARI:

0.52

LNTH:

1.34

Martin Ratio

NARI:

1.80

LNTH:

4.26

Ulcer Index

NARI:

20.43%

LNTH:

15.38%

Daily Std Dev

NARI:

62.62%

LNTH:

60.77%

Max Drawdown

NARI:

-70.53%

LNTH:

-78.62%

Current Drawdown

NARI:

-36.82%

LNTH:

-26.01%

Fundamentals

Market Cap

NARI:

$4.66B

LNTH:

$6.36B

EPS

NARI:

-$1.35

LNTH:

$6.01

Total Revenue (TTM)

NARI:

$442.40M

LNTH:

$1.14B

Gross Profit (TTM)

NARI:

$380.12M

LNTH:

$749.68M

EBITDA (TTM)

NARI:

-$35.21M

LNTH:

$493.72M

Returns By Period

In the year-to-date period, NARI achieves a 55.83% return, which is significantly higher than LNTH's 2.25% return.


NARI

YTD

55.83%

1M

43.46%

6M

44.06%

1Y

38.37%

5Y*

N/A

10Y*

N/A

LNTH

YTD

2.25%

1M

2.45%

6M

-20.24%

1Y

72.32%

5Y*

37.45%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NARI vs. LNTH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NARI
The Risk-Adjusted Performance Rank of NARI is 6767
Overall Rank
The Sharpe Ratio Rank of NARI is 6666
Sharpe Ratio Rank
The Sortino Ratio Rank of NARI is 7070
Sortino Ratio Rank
The Omega Ratio Rank of NARI is 6969
Omega Ratio Rank
The Calmar Ratio Rank of NARI is 6767
Calmar Ratio Rank
The Martin Ratio Rank of NARI is 6464
Martin Ratio Rank

LNTH
The Risk-Adjusted Performance Rank of LNTH is 8181
Overall Rank
The Sharpe Ratio Rank of LNTH is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of LNTH is 8282
Sortino Ratio Rank
The Omega Ratio Rank of LNTH is 8383
Omega Ratio Rank
The Calmar Ratio Rank of LNTH is 8484
Calmar Ratio Rank
The Martin Ratio Rank of LNTH is 7878
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NARI vs. LNTH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Inari Medical, Inc. (NARI) and Lantheus Holdings, Inc. (LNTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NARI, currently valued at 0.59, compared to the broader market-2.000.002.004.000.591.08
The chart of Sortino ratio for NARI, currently valued at 1.44, compared to the broader market-4.00-2.000.002.004.006.001.442.11
The chart of Omega ratio for NARI, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.29
The chart of Calmar ratio for NARI, currently valued at 0.52, compared to the broader market0.002.004.006.000.521.34
The chart of Martin ratio for NARI, currently valued at 1.80, compared to the broader market-10.000.0010.0020.0030.001.804.26
NARI
LNTH

The current NARI Sharpe Ratio is 0.59, which is lower than the LNTH Sharpe Ratio of 1.08. The chart below compares the historical Sharpe Ratios of NARI and LNTH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
0.59
1.08
NARI
LNTH

Dividends

NARI vs. LNTH - Dividend Comparison

Neither NARI nor LNTH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NARI vs. LNTH - Drawdown Comparison

The maximum NARI drawdown since its inception was -70.53%, smaller than the maximum LNTH drawdown of -78.62%. Use the drawdown chart below to compare losses from any high point for NARI and LNTH. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%AugustSeptemberOctoberNovemberDecember2025
-36.82%
-26.01%
NARI
LNTH

Volatility

NARI vs. LNTH - Volatility Comparison

Inari Medical, Inc. (NARI) has a higher volatility of 34.26% compared to Lantheus Holdings, Inc. (LNTH) at 9.38%. This indicates that NARI's price experiences larger fluctuations and is considered to be riskier than LNTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%AugustSeptemberOctoberNovemberDecember2025
34.26%
9.38%
NARI
LNTH

Financials

NARI vs. LNTH - Financials Comparison

This section allows you to compare key financial metrics between Inari Medical, Inc. and Lantheus Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab